Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced Metastatic Breast Cancer

NCT07850869 is registered in ClinicalTrials.gov with Jie Yuan，MD as lead sponsor.

NCT NCT07850869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07850869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced Metastatic Breast Cancer
Lead sponsor
Jie Yuan，MD
Phase
Observational
Overall status
Recruiting
Start date
September 9, 2026
Completion date
February 29, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer (locally advanced or metastatic)